MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Risk and timing of manifest Huntington’s disease in patients with reduced penetrance alleles

    E. Mcdonnell, Y. Wang, K. Marder (New York, USA)

    Objective: To estimate risk of Huntington’s disease (HD) over time in patients with reduced penetrance (RP) alleles (36-39 CAG repeats) overall, by individual repeat length,…
  • MDS Virtual Congress 2021

    Gabapentin-induced severe myoclonus in a patient with impaired renal function

    M. Akkari, M. Messelmani, H. Derbali, M. Mansour, A. Riahi, I. Bedoui, J. Zaouali, R. Mrissa (Tunis, Tunisia)

    Objective: The aim of this study was to present myoclonus as a reversible side effect of gabapentin in order to bring this trend to clinician’s…
  • MDS Virtual Congress 2021

    Clinical variants of PSP: phenotypical convergence and its relationship with the brain glucose metabolism

    G. Martí-Andrés, D. Vállez-García, E. Prieto, L. van Bommel, S. Meles, R. Valentí, R. Kogan, V. Gurvits, M. Riverol, MR. Luquin, KL. Leenders, J. Arbizu (Pamplona, Spain)

    Objective: To evaluate the phenotypical convergence phenomena among a cohort of different PSP variants. We also aimed to evaluate the possible correlations of the regional…
  • MDS Virtual Congress 2021

    GALLIC ACID AMELIORATES THE NEUROBEHAVIOURAL DEFICITS INDUCED BY BISPHENOL A (BPA) IN WISTAR RATS

    K. Adigun, M. Ehinmowo, A. Adebiyi, O. Adebiyi (Ibadan, Nigeria)

    Objective: Bisphenol A (BPA) has been found to exert neurotoxic effects through its neuroendocrine disruption and generation of reactive oxygen species (ROS). It can also…
  • MDS Virtual Congress 2021

    New-onset movement disorders in patients with COVID-19 from two centers in Western India

    S. Adukia, S. Panat, M. Munshi, P. Joshi, K. Shetty, T. Singhal, M. Bhatt, A. Aggarwal (Mumbai, India)

    Objective: To study the frequency and characteristics of movement disorders in patients with COVID-19 at two tertiary-care hospitals in Western India. Background: As of March…
  • MDS Virtual Congress 2021

    Subacute cerebellar degeneration and Holmes tremor secondary to paraneoplastic non-Hodgkin’s lymphoma

    J. Frey, J. Toledo, A. Ramirez-Zamora, I. Malaty (Gainesville, USA)

    Objective: To describe a paraneoplastic cerebellar syndrome with Holmes tremor secondary to a novel antibody. Background: Holmes tremor is a large amplitude, 3-4 Hz tremor…
  • MDS Virtual Congress 2021

    Stiff Person Syndrome Presenting with Dystonia

    F. Gao (Honolulu, USA)

    Objective: To describe a case report of a patient with stiff person syndrome presenting with dystonia. Background: Stiff person syndrome (SPS) is a rare autoimmune…
  • MDS Virtual Congress 2021

    Advocacy for Neuropalliative Care in Parkinson Disease Care: The Need for an International Neuropalliative Care Society (INPCS)

    U. Ramanathan, C. Chou, E. Richfield, D. Oliver, C. Creutzfeldt, B. Kluger (Toronto, Canada)

    Objective: To describe the International Neuropalliative Care Society (INPCS), its mission and values, and highlight the importance of palliative care for persons with movement disorders.…
  • MDS Virtual Congress 2021

    Evaluation of Motor Function Using Motor Testing App and Deep Learning for the Treatment of Lewy Body Dementia

    X. Dang, Y. Guan, K. Deng, J. Wang, H. Zhang, C. Battioui, M. Pugh, B. Winger, J. Yang, K. Biglan (Cambridge, USA)

    Objective: To construct deep learning (DL) models using finger tapping data and apply them in PRESENCE to evaluate treatment effect in motor function. Background: PRESENCE…
  • MDS Virtual Congress 2021

    Effects of safinamide adjunct therapy on non-motor symptoms in patients with Parkinson’s disease: a post-hoc analysis of the Japanese Phase 2/3 study

    N. Hattori, Y. Tsuboi, Y. Kogo, M. Koebisu, T. Ishida, I. Suzuki, M. Nomoto (Tokyo, Japan)

    Objective: To evaluate the efficacy of safinamide for mood and pain by a post-hoc analysis of the Japanese phase 2/3 double-blind study (JapicCTI-153056) in patients…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • #24970 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley